This shouldn’t be a priority for the Oregon Health Authority, particularly amid a pandemic with no clear end in sight… …the measure [estimated to cost over 6 million dollars during the next two years], if passed, would give the Oregon Health Authority two years to work with [a self-appointed] advisory board in developing the regulatory…
Field Trip [Oregon Measure 109 donor] went public through a direct listing on the Canadian Securities Exchange after it completed a reverse takeover of oil and gas company Newton Energy Corporation. Field Trip, which is not profitable and incurred a net loss of $2 million, has a three-pronged approach to the psychedelics market – treatment…
I cannot support Measure 109 for the following reasons… there are two different ballot measures this fall that would change state law (and only state law) regarding the possession and use of psilocin – the active ingredient in “magic” psilocybin mushrooms. The proponents of Measure 109 are focused on setting up specialty facilities and services…
We talked to a supporter and opponent… [Nichole, an opponent], “We do not feel it is safe to be giving Oregonians psilocybin…” and also states that the science is not ready to support psilocybin use for mental health conditions as Measure 109 claims… other local and national organizations also oppose the measure. [Thomas, a supporter]:…
The term “patent troll” best describes… [those seeking] to extract royalties from other practicing entities by leveraging its patent portfolio [in Cahoots with the Controlled Substances Act of 1970]. On the one hand, [for-profit psychedelic actors are] candid about their lack of interest in clinically developing their compounds in favor of “partnering” with others interested in…
…[a] willingness to accept funding from all-things-conservative financier Rebekah Mercer and ATAI Life Sciences’ founder Christian Angermayer, and its unwillingness to speak out against Peter Thiel, the chairman of Palantir and recent investor in defense-contractor startup Anduril. As long as its strategy relies on supporting the police and the military (institutions that exist to perpetuate white supremacism, class warfare, and imperialism) it’s…
“A very special tattoo – actually my first one ever – for a very special day…” -[said Christian Angermayer]… “Palantir is going public, meaning they will be able to make money on Wall Street while working [with] ICE,” MSC wrote in a tweet. Many of the outside backers that Angermayer brought into Compass are also…
COMPASS patent… compared to proprietary insulin formulations and asthma inhalers created to increase corporate profits… will share similar issues to “big pharma, big tech, big ag [agriculture], and other monopoly-heavy industries.” COMPASS’s attempt to dismiss the dispute against their patent… “Although Patent Owner does not address the substance of Petitioner’s challenge, after considering the arguments…
The London-based firm filed to raise US$100 million, a placeholder amount likely to change, according to a filing Friday [8/28/2020] with the U.S. Securities and Exchange Commission. …has seen a renaissance in recent years in the scientific community. Scientists can’t exactly explain why psychedelics appear to help patients. Emerging brain-scanning technology suggests the substances can…
…hope to be granted FDA approval as early as 2022. Asked about the role that the localized psychedelics reform movement might have played in the fundraising campaign, MAPS Founder Rick Doblin… [said] that their research objectives and the activists’ legislative objectives have complemented each other. “I really think that the movements are in parallel,” he…
